Skip to main navigation

Skip to navigation (n)
Skip to content (c)
Skip to footer (f)

Client nav

About Arcturus
Nucleic Acid Medicines
Technologies
Pipeline
Business Development
Investor Relations

Quarterly Results

Show all

2018

Q3

Arcturus Therapeutics Provides Corporate Update and Reports Third Quarter 2018 Financial Results

Investor Home

Corporate Governance

Governance Highlights
Management Team
Board of Directors
Committee Composition

Financials & Filings

SEC Filings
Annual Reports
Quarterly Results

News & Events

Press Releases
Videos
Media Coverage
Events & Presentations

Stock Information

Stock Quote
Historical Price Lookup
Analyst Coverage

Investor Resources

Investor FAQ
Contact IR
Email Alerts

Home
Contact
Careers
Legal

© 2019 Arcturus Therapeutics, Inc.

Search